Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard Therapy
Clinical trial NCT00782002 · COMPLETED
Trial details
- NCT number
- NCT00782002
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2009-03-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.